Related Experiment Videos

Risk-benefit assessment of antiarrhythmic drugs. An epidemiological perspective

L Friedman1, E Schron, S Yusuf

  • 1Clinical Trials Branch, National Heart, Lung, and Blood Institute, Bethesda, Maryland.

Drug Safety
|September 1, 1991
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos